Veradigm Shares Outstanding 2010-2022 | MDRX
Veradigm shares outstanding from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Veradigm Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022 | 112 |
| 2021 | 139 |
| 2020 | 159 |
| 2019 | 166 |
| 2018 | 176 |
| 2017 | 181 |
| 2016 | 186 |
| 2015 | 185 |
| 2014 | 180 |
| 2013 | 177 |
| 2012 | 179 |
| 2011 | 191 |
| 2010 | 168 |
| 2010 | 148 |
| 2009 | 127 |
| Veradigm Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022-12-31 | 112 |
| 2022-09-30 | 129 |
| 2022-06-30 | 119 |
| 2022-03-31 | 139 |
| 2021-12-31 | 139 |
| 2021-09-30 | 131 |
| 2021-06-30 | 145 |
| 2021-03-31 | 149 |
| 2020-12-31 | 159 |
| 2020-09-30 | 161 |
| 2020-06-30 | 163 |
| 2020-03-31 | 162 |
| 2019-12-31 | 166 |
| 2019-09-30 | 166 |
| 2019-06-30 | 167 |
| 2019-03-31 | 170 |
| 2018-12-31 | 176 |
| 2018-09-30 | 175 |
| 2018-06-30 | 179 |
| 2018-03-31 | 180 |
| 2017-12-31 | 181 |
| 2017-09-30 | 181 |
| 2017-06-30 | 181 |
| 2017-03-31 | 181 |
| 2016-12-31 | 186 |
| 2016-09-30 | 186 |
| 2016-06-30 | 187 |
| 2016-03-31 | 191 |
| 2015-12-31 | 185 |
| 2015-09-30 | 189 |
| 2015-06-30 | 182 |
| 2015-03-31 | 181 |
| 2014-12-31 | 180 |
| 2014-09-30 | 180 |
| 2014-06-30 | 180 |
| 2014-03-31 | 179 |
| 2013-12-31 | 177 |
| 2013-09-30 | 178 |
| 2013-06-30 | 178 |
| 2013-03-31 | 174 |
| 2012-12-31 | 179 |
| 2012-09-30 | 173 |
| 2012-06-30 | 185 |
| 2012-03-31 | 193 |
| 2011-12-31 | 191 |
| 2011-09-30 | 191 |
| 2011-06-30 | 193 |
| 2011-03-31 | 193 |
| 2010-12-31 | 187 |
| 2010-09-30 | 160 |
| 2010-06-30 | 149 |
| 2010-05-31 | |
| 2010-03-31 | 149 |
| 2010-02-28 | 148 |
| 2009-12-31 | |
| 2009-11-30 | 151 |
| 2009-09-30 | 148 |
| 2009-08-31 | 150 |
| 2009-05-31 | |
| 2009-02-28 | 151 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.455B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
| Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
| Tempus AI (TEM) | United States | $11.278B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.503B | 70.35 |
| IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $2.060B | 11.48 |
| Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
| Schrodinger (SDGR) | United States | $1.722B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.310B | 23.11 |
| Azenta (AZTA) | United States | $1.258B | 58.45 |
| 10x Genomics (TXG) | United States | $1.148B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.67 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 3.39 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |